Pathway Genomics Corporation Launches Hereditary Colorectal Cancer Genetic Test
Published: Feb 18, 2014
SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA InsightSM, the company’s premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient’s risk of developing certain types of cancer.
Help employers find you! Check out all the jobs and post your resume.